Goldman Capital Management Reduces Stake in Bacterin International Holdings Inc (BONE)
Goldman Capital Management Inc has reduced its exposure to Bacterin International Holdings Inc (NYSEMKT:BONE).
Posts Tagged ‘James E. Flynn Deerfield Management’
Why Does Polaris Capital Love Teva Pharmaceutical Industries Ltd (ADR) (TEVA) & Infosys Ltd ADR (INFY)?
Bernard Horn, the manager of Polaris Capital Management, is a former employee of MDT Advisers.
Bacterin International Holdings Inc (BONE) Is a New Pick For This Hedgie: The Details
In the smart money’s world, James E.
Cross Country Healthcare, Inc. (CCRN): Are Hedge Funds Right About This Stock?
In the eyes of most market participants, hedge funds are perceived as unimportant, outdated financial tools of yesteryear.
Here is What Hedge Funds Think About AngioDynamics, Inc. (ANGO)
AngioDynamics, Inc. (NASDAQ:ANGO) was in 11 hedge funds' portfolio at the end of the first quarter of 2013.
Do Hedge Funds and Insiders Love Alnylam Pharmaceuticals, Inc. (ALNY)?
To most traders, hedge funds are assumed to be unimportant, old investment vehicles of years past.
Is Array Biopharma Inc (ARRY) Going to Burn These Hedge Funds?
If you'd ask most shareholders, hedge funds are seen as slow, old investment vehicles of the past.
Hedge Funds Are Buying Keryx Biopharmaceuticals (KERX)
In today’s marketplace, there are many gauges investors can use to track publicly traded companies. A couple of the best are hedge fund and insider trading sentiment.
Do Hedge Funds and Insiders Love NuVasive, Inc. (NUVA)?
NuVasive, Inc. (NASDAQ:NUVA) was in 18 hedge funds' portfolio at the end of March. NUVA investors should be aware of a decrease in hedge fund interest recently.
Here is What Hedge Funds Think About Questcor Pharmaceuticals Inc (QCOR)
Questcor Pharmaceuticals Inc (NASDAQ:QCOR) was in 26 hedge funds' portfolio at the end of March.
Hedge Funds Are Selling Endo Health Solutions Inc (ENDP)
Endo Health Solutions Inc (NASDAQ:ENDP) was in 23 hedge funds' portfolio at the end of March.
Arena Pharmaceuticals, Inc. (ARNA): One Mind-Blowing Metric Screaming ‘Buy’
Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) an exceptional investment now? Prominent investors are taking a bullish view.
Do Hedge Funds and Insiders Love Durata Therapeutics Inc (DRTX)?
Durata Therapeutics Inc (NASDAQ:DRTX) was in 5 hedge funds' portfolio at the end of December.
Here is What Hedge Funds Think About Antares Pharma Inc (ATRS)
In the 21st century investor’s toolkit, there are a multitude of metrics shareholders can use to track the equity markets.
Hedge Funds Aren’t Crazy About Cytokinetics, Inc. (CYTK) Anymore
In today’s marketplace, there are a multitude of indicators market participants can use to analyze their holdings.
Pacific Biosciences of California (PACB): Insiders Are Buying, Should You?
Is Pacific Biosciences of California (NASDAQ:PACB) the right pick for your portfolio? Investors who are in the know are getting more optimistic.
AngioDynamics, Inc. (ANGO): Are Hedge Funds Right About This Stock?
In the eyes of most stock holders, hedge funds are seen as worthless, outdated investment tools of the past.
Here is What Hedge Funds Think About Depomed Inc (DEPO): Synergy Pharmaceuticals Inc (SGYP), SciClone Pharmaceuticals, Inc. (SCLN)
According to most investors, hedge funds are seen as underperforming, outdated financial tools of the past.
Here is What Hedge Funds Think About Vanguard Health Systems, Inc. (NYSE:VHS): Community Health Systems (CYH), Health Management Associates Inc (HMA)
To the average investor, there are a multitude of gauges investors can use to monitor stocks. Some of the most useful are hedge fund and insider trading interest.
Hedge Funds Are Dumping Dendreon Corporation (DNDN): Achillion Pharmaceuticals, Inc. (ACHN), TESARO Inc (TSRO)
If you'd ask most traders, hedge funds are perceived as underperforming, outdated investment tools of years past.
Do Hedge Funds and Insiders Love Arena Pharmaceuticals, Inc. (ARNA)?: Charles River Laboratories (CRL), Synageva BioPharma Corp (GEVA)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) was in 11 hedge funds' portfolio at the end of the fourth quarter of 2012.
This Metric Says You Are Smart to Buy Dynavax Technologies Corporation (DVAX): Orexigen Therapeutics, Inc. (OREX), Lannett Company, Inc. (LCI)
Dynavax Technologies Corporation (NASDAQ:DVAX) was in 11 hedge funds' portfolio at the end of the fourth quarter of 2012.
Should You Avoid Accuray Incorporated (ARAY)?: GenMark Diagnostics, Inc (GNMK), Natus Medical Inc (BABY)
Accuray Incorporated (NASDAQ:ARAY) was in 13 hedge funds' portfolio at the end of the fourth quarter of 2012.
Hedge Funds Aren’t Crazy About MAKO Surgical Corp. (MAKO) Anymore: The Spectranetics Corporation (SPNC), Symmetry Medical Inc. (SMA)
MAKO Surgical Corp. (NASDAQ:MAKO) was in 13 hedge funds' portfolio at the end of December. MAKO investors should pay attention to a decrease in hedge fund interest lately.
XenoPort, Inc. (NASDAQ:XNPT): Insiders Are Dumping, Should You?: Obagi Medical Products, Inc. (OMPI), Vical Incorporated (VICL)
XenoPort, Inc. (NASDAQ:XNPT) was in 13 hedge funds' portfolio at the end of December.
Is ArQule, Inc. (ARQL) Going to Burn These Hedge Funds?: ShangPharma Corp (ADR) (SHP), OncoGenex Pharmaceuticals Inc (OGXI)
ArQule, Inc. (NASDAQ:ARQL) was in 13 hedge funds' portfolio at the end of December. ARQL investors should pay attention to a decrease in hedge fund sentiment in recent months.
This Metric Says You Are Smart to Buy Sarepta Therapeutics Inc (SRPT): Acorda Therapeutics Inc (ACOR), Nektar Therapeutics (NKTR)
According to most traders, hedge funds are perceived as underperforming, old investment tools of yesteryear.
InterMune Inc (NASDAQ:ITMN): Insiders Are Dumping, Should You?
InterMune Inc (NASDAQ:ITMN) was in 14 hedge funds' portfolio at the end of the fourth quarter of 2012. ITMN has seen a decrease in hedge fund interest of late.
Here is What Hedge Funds Think About Universal American Corporation (NYSE:UAM)
Universal American Corporation (NYSE:UAM) was in 16 hedge funds' portfolio at the end of December. UAM has seen a decrease in enthusiasm from smart money of late.
Is St. Jude Medical, Inc. (NYSE:STJ) Going to Burn These Hedge Funds?
St. Jude Medical, Inc. (NYSE:STJ) was in 27 hedge funds' portfolio at the end of December. STJ shareholders have witnessed a decrease in enthusiasm from smart money of late.
Is Molina Healthcare, Inc. (NYSE:MOH) Going to Burn These Hedge Funds?
To most stock holders, hedge funds are seen as slow, outdated financial tools of the past.
Hedge Funds Aren’t Crazy About Questcor Pharmaceuticals Inc (NASDAQ:QCOR) Anymore
According to most shareholders, hedge funds are seen as worthless, outdated investment vehicles of yesteryear.
